UNSPSC 51111611: Teniposide

This classification denotes an epipodophyllotoxin compound, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 957E6438QA. European Medicines Agency schedules Teniposide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10895MIG. Teniposide generally arises in the molecular formula C32H32O13S.

UNSPSC 51111611 Teniposide is a Commodity code covering procurement of this semi-synthetic podophyllotoxin derivative, a topoisomerase II inhibitor used as a chemotherapy agent in pediatric and adult acute leukemia treatment protocols. State and local governments acquire teniposide primarily through health departments, public hospital systems, and correctional health services that operate inpatient and outpatient oncology programs. The drug is typically procured as a sterile injectable solution in single-dose or multi-dose vials through pharmaceutical supply contracts or cooperative purchasing agreements that bundle cancer therapeutics.

The source provided contains no record of recent state and local solicitations under this code. Without active RFP, RFQ, IFB, or ITB activity in the recent-opportunities dataset, the current procurement velocity and geographic distribution cannot be characterized from available contract notices.